dc.contributorUniversidade Estadual Paulista (Unesp)
dc.contributorSynchrotron SOLEIL
dc.date.accessioned2014-05-20T15:31:47Z
dc.date.available2014-05-20T15:31:47Z
dc.date.created2014-05-20T15:31:47Z
dc.date.issued2012-01-01
dc.identifierRsc Advances. Cambridge: Royal Soc Chemistry, v. 2, n. 13, p. 5629-5636, 2012.
dc.identifier2046-2069
dc.identifierhttp://hdl.handle.net/11449/40834
dc.identifier10.1039/c2ra01216b
dc.identifierWOS:000305274600031
dc.identifier5584298681870865
dc.identifier9971202585286967
dc.identifier0000-0002-8356-8093
dc.description.abstractThe objective of this work was to study the interactions between a model drug, sodium diclofenac (SDCF), and ureasil-poly(ethylene oxide) (PEO) hybrid materials, aiming to understand and to optimize the drug delivery behaviour. Ureasil-PEO hybrids obtained by the sol-gel process and containing short (PEO500) and long (PEO1900) polymer chains were prepared. Differential scanning calorimetry (DSC), Raman spectroscopy and Si-29 NMR were used to investigate the interactions between SDCF and the hybrid matrix. The decrease in melting temperature of the semi-crystalline PEO1900 hybrid from 30.1 (SDCF-free matrix) to 22.3 degrees C (SDCF-loaded matrix) and the decrease of the T-g values of about -3 degrees C in SDCF-loaded PEO500 matrices associated to the Raman results confirm the interactions between SDCF and the PEO chains of the hybrid matrix. The role of the coexistence of crystalline and amorphous hybrid phase was clearly evinced by the bimodal drug release pattern achieved for the PEO1900 matrix.
dc.languageeng
dc.publisherRoyal Soc Chemistry
dc.relationRsc Advances
dc.relation2.936
dc.relation0,863
dc.rightsAcesso restrito
dc.sourceWeb of Science
dc.titleDrug-matrix interaction of sodium diclofenac incorporated into ureasilpoly(ethylene oxide) hybrid materials
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución